1.
Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma.
Hirooka Kazuyuki, Baba Tetsuya, Fujimura Takashi, Shiraga Fumio
Am J OphthalmolSep 200624 citationsCase Series
This study suggests ACE inhibitors may slow visual field progression in normal-tension glaucoma patients, offering a potential neuroprotective strategy.